查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1978141

2026-2034年全球藥品無菌檢測市場規模、佔有率、趨勢及成長分析報告

Global Pharmaceutical Sterility Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年，藥品無菌檢測市場規模將從 2025 年的 25.4 億美元成長至 69.8 億美元，2026 年至 2034 年的複合年成長率為 11.89%。

由於對藥品安全性和品質保證的監管要求日益嚴格，藥品無菌檢測市場正穩定成長。生物製藥的不斷增加，推動了對可靠無菌檢測方法的需求。全球監管機構都在強制執行嚴格的無菌標準，鼓勵製藥公司採用先進的檢測技術。

成長要素包括藥品生產的擴張、研發活動的增加以及需要無菌注射療法的慢性病患者數量的上升。快速微生物檢測系統和實驗室流程的自動化提高了效率並縮短了檢測時間。受託研究機構(CRO) 將檢測服務外包也促進了市場擴張。

展望未來，快速微生物檢測技術的創新和生物製藥生產投資的增加預計將對市場產生積極影響。在新興市場，法規結構的完善預計將進一步推動需求。隨著全球藥物研發管線的擴展，無菌檢測仍將是藥品生產和品管的關鍵環節。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球藥品無菌檢測市場：依類型分類

  • 市場分析、洞察與預測
  • 內部
  • 外包

第5章 全球藥品無菌檢測市場：依產品分類

  • 市場分析、洞察與預測
  • 試劑盒和試劑
  • 裝置
  • 服務

第6章 全球藥品無菌檢測市場：依檢測類型分類

  • 市場分析、洞察與預測
  • 無菌檢測（薄膜過濾法、直接接種法、產品沖洗法）
  • 微生物附著量測試
  • 細菌內毒素檢測

第7章 全球藥品無菌檢測市場：依樣本數分類

  • 市場分析、洞察與預測
  • 製藥
  • 醫療設備
  • 生物製藥

第8章：全球藥品無菌檢測市場：依最終用途分類

  • 市場分析、洞察與預測
  • 藥局
  • 醫療設備製造商
  • 製藥公司
  • 其他

第9章 全球藥品無菌檢測市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Pacific Biolabs
    • Steris Plc
    • Boston Analytical
    • Sotera Health Company（Nelson Labs）
    • Sartorius AG
    • Solvias AG
    • SGS SA
    • Labcorp
    • Pace Analytical
    • Charles River Laboratories
    • Thermo Fisher Scientific Inc
    • Rapid Micro Biosystems Inc
簡介目錄
Product Code: VMR112113912

The Pharmaceutical Sterility Testing Market size is expected to reach USD 6.98 Billion in 2034 from USD 2.54 Billion (2025) growing at a CAGR of 11.89% during 2026-2034.

The pharmaceutical sterility testing market is growing steadily due to stringent regulatory requirements for drug safety and quality assurance. The rising production of biologics, vaccines, and injectable drugs has increased the demand for reliable sterility testing methods. Regulatory bodies worldwide mandate strict sterility standards, encouraging pharmaceutical manufacturers to adopt advanced testing technologies.

Growth drivers include expanding pharmaceutical manufacturing, increasing research and development activities, and the growing prevalence of chronic diseases requiring sterile injectable treatments. Rapid microbial detection systems and automation in laboratory procedures are improving efficiency and reducing testing time. Contract research organizations are also contributing to market expansion through outsourced testing services.

Looking ahead, the market is expected to benefit from technological innovations in rapid microbiological testing and increased investments in biopharmaceutical production. Emerging markets are strengthening their regulatory frameworks, further driving demand. As pharmaceutical pipelines expand globally, sterility testing will remain a critical component of drug manufacturing and quality control.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • In-House
  • Outsourcing

By Product

  • Kits and Reagents
  • Instruments
  • Services

By Test Type

  • Sterility Testing (Membrane Filtration, Direct Inoculation, Product Flush)
  • Bioburden Testing
  • Bacterial Endotoxin Testing

By Sample

  • Pharmaceuticals
  • Medical Devices
  • Biopharmaceuticals

By End-use

  • Compounding Pharmacies
  • Medical Device Companies
  • Pharmaceutical Companies
  • Others

COMPANIES PROFILED

  • Pacific Biolabs, Steris Plc, Boston Analytical, Sotera Health Company Nelson Labs, Sartorius AG, Solvias AG, SGS SA, Labcorp, Pace Analytical, Charles River Laboratories, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. In-House Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Outsourcing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product
  • 5.2. Kits and Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Test Type
  • 6.2. Sterility Testing (Membrane Filtration, Direct Inoculation, Product Flush) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Bioburden Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Bacterial Endotoxin Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET: BY SAMPLE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Sample
  • 7.2. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Medical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Biopharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET: BY END-USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End-use
  • 8.2. Compounding Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Type
    • 9.2.2 By Product
    • 9.2.3 By Test Type
    • 9.2.4 By Sample
    • 9.2.5 By End-use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Type
    • 9.3.2 By Product
    • 9.3.3 By Test Type
    • 9.3.4 By Sample
    • 9.3.5 By End-use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Type
    • 9.4.2 By Product
    • 9.4.3 By Test Type
    • 9.4.4 By Sample
    • 9.4.5 By End-use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Type
    • 9.5.2 By Product
    • 9.5.3 By Test Type
    • 9.5.4 By Sample
    • 9.5.5 By End-use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Type
    • 9.6.2 By Product
    • 9.6.3 By Test Type
    • 9.6.4 By Sample
    • 9.6.5 By End-use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL PHARMACEUTICAL STERILITY TESTING INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Pacific Biolabs
    • 11.2.2 Steris Plc
    • 11.2.3 Boston Analytical
    • 11.2.4 Sotera Health Company (Nelson Labs)
    • 11.2.5 Sartorius AG
    • 11.2.6 Solvias AG
    • 11.2.7 SGS SA
    • 11.2.8 Labcorp
    • 11.2.9 Pace Analytical
    • 11.2.10 Charles River Laboratories
    • 11.2.11 Thermo Fisher Scientific Inc
    • 11.2.12 Rapid Micro Biosystems Inc